These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24260892

  • 1. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
    Rybalkina EIu, Stromskaia TP, Ovchinnikov LP, Stavrovskaia AA.
    Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
    [Abstract] [Full Text] [Related]

  • 2. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y, Qu XJ, Liu YP, Yang XH, Hou KZ, Teng YE, Zhang JD.
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity.
    Saupe M, Rauschenberger L, Preuß M, Oswald S, Fussek S, Zimmermann U, Walther R, Knabbe C, Burchardt M, Stope MB.
    World J Urol; 2015 Oct; 33(10):1481-6. PubMed ID: 25544376
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.
    Liu Z, Zhu G, Getzenberg RH, Veltri RW.
    J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression.
    McDonald GT, Sullivan R, Paré GC, Graham CH.
    Exp Cell Res; 2010 Nov 15; 316(19):3197-206. PubMed ID: 20736003
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Connection between Proliferation Rate and Temozolomide Sensitivity of Primary Glioblastoma Cell Culture and Expression of YB-1 and LRP/MVP.
    Moiseeva NI, Susova OY, Mitrofanov AA, Panteleev DY, Pavlova GV, Pustogarov NA, Stavrovskaya AA, Rybalkina EY.
    Biochemistry (Mosc); 2016 Jun 15; 81(6):628-35. PubMed ID: 27301292
    [Abstract] [Full Text] [Related]

  • 14. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Sakai K, Shimoyama T, Nishio K, Kuwano M.
    Oncogene; 2007 Apr 26; 26(19):2736-46. PubMed ID: 17072343
    [Abstract] [Full Text] [Related]

  • 15. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
    Barancík M, Bohácová V, Sedlák J, Sulová Z, Breier A.
    Eur J Pharm Sci; 2006 Dec 26; 29(5):426-34. PubMed ID: 17010577
    [Abstract] [Full Text] [Related]

  • 16. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 26; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 17. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
    Sinnberg T, Sauer B, Holm P, Spangler B, Kuphal S, Bosserhoff A, Schittek B.
    Exp Dermatol; 2012 Apr 26; 21(4):265-70. PubMed ID: 22417301
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B, Psenner K, Sauer B, Meier F, Iftner T, Garbe C.
    Int J Cancer; 2007 May 15; 120(10):2110-8. PubMed ID: 17266041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.